Abstract
Study 1.
Aim. To review the published literature that could
provide information on the development, extent, and predictors of psychiatric
comorbidity with substance use and abuse in children and adolescents.
Method. From a review of 141 published papers, 21 were identified
that could contribute to a meta-analysis of the extent of comorbidity
with three disruptive behavior disorders (DBDs): conduct disorder (CD),
oppositional defiant disorder (ODD), and attention deficit hyperactivity
disorder (ADHD), and with depression and anxiety. Results. Comorbidity
was highest with the DBDs and lowest with anxiety. Controlling for comorbidity
among psychiatric disorders reduced the odds ratios but maintained their
relative ranking. Odds ratios for comorbidity with substance abuse/dependence
were higher than those for any use. The excess risk associated with
abuse/dependence compared with any use was highest for ADHD and depression,
lowest for CD. Sex was the only correlate available for meta-analytic
review of causes and correlates. For both abuse/dependence and any use,
the odds ratios for comorbidity were higher in girls than boys, significantly
so for CD and anxiety. Conclusions. While psychiatric comorbidity
with drug abuse is high, varying by diagnosis, published data are lacking
on correlates, risk factors, temporal ordering, and treatment.
Study 2.
Aim. To review the information available in existing
data sets that could contribute to a more detailed examination of correlates
and risk factors of psychiatric comorbidity with substance use and abuse,
and of the temporal relationships between psychiatric disorders and
drug abuse. Methods. We identified 65 potentially useful data
sets, and sent out a questionnaire to the Principal Investigators. Results.
Sixteen data sets met the minimal requirements of representative sampling,
psychiatric diagnoses, data on drug abuse, and information on timing.
Most were panel studies with repeated assessments of participants. Data
are available on over 17,000 youth, providing some 84,000 person-observations
over time. Of these, 50 percent are female, about 3,500 (11,000 person-observations)
are African American, 2,700 (6,000 person-observations) are Hispanic,
and 450 (2,000 person-observations) are American Indian. The age ranges
of the studies cover the period from birth through age 26. Conclusions.
Given modern methods of data analysis, and the impressive resource represented
by the data sets available, there is a real opportunity to advance understanding
of the predictors and timing of psychiatric comorbidity with drug abuse,
using existing data.
Back to Top
Introduction
In this report we present an overview of the data available
to estimate the co-occurrence of psychiatric disorders with drug use,
abuse, and dependence in childhood and adolescence. We provide this
as background to the discussion of the impact of childhood interventions
on subsequent drug use.
In order for childhood interventions to have an effect
on subsequent drug abuse, they need to affect risk factors for later
drug use. In these analyses we concentrate on psychiatric disorders
of childhood and adolescence as potential risk factors for later drug
abuse. The policy question is where it makes most sense to target early
interventions. For example, if depression and drug abuse co-occur in
childhood, an intervention program could have an effect on future drug
abuse by reducing current drug use, or by ameliorating current depression,
or both. A program targeting only childhood drug use might have little
effect on children put at risk for future drug abuse primarily by their
history of depression, while a program targeting only childhood depression
might have little effect on youth put at risk by early drug use. If
childhood depression and drug use co-occur, it would be helpful for
program planners to know how often, whether the risk is the same across
the population, or is higher in some groups, and how depression affects
the risk of later drug abuse as children move into adolescence and early
adulthood. The same is true of other psychiatric disorders of childhood.
The first question, then, is how often drug use and abuse
co-occur with psychiatric disorders. Second, one would like to know
whether co-occurrence is more common with some disorders than with others,
and conversely, whether some forms of drug abuse are more likely than
others to be comorbid with specific psychiatric disorders. Third, are
some groups of children (boys or girls, younger or older children, White
or minority groups, poor or nonpoor, urban or rural) more at risk than
others of co-occurring psychiatric disorders and drug abuse? Fourth,
understanding the temporal sequencing of psychiatric disorders and drug
abuse would help in planning interventions. In particular, it would
be helpful to know how a disorder that co-occurs with drug abuse in
childhood or adolescence affects later risk of drug abuse. With this
information available, it might be possible to estimate the attributable
risk, or the proportion of later drug abuse that would be prevented
by intervening with one risk factor (e.g., early depression) rather
than another (e.g., early drug use). This kind of calculation is often
useful to policy planners making cost-/efficiency-based choices among
programs.
In this report we review the data relevant to the first
and second questions: the co-occurrence of specific psychiatric disorders
with drug use and abuse/dependence in children and adolescents. We present
a meta-analysis of comorbidity with five different groups of psychiatric
disorders based on the published literature. Questions 3 and 4 cannot
yet be answered from the published literature, but in the second part
of this report we provide an overview of existing data sets that have
the potential to provide answers to some of these questions.
Back to Top
|